Saturday, September 25, 2021 3:50:08 PM
Ya know Anders, if I pulled my park bench (that I live on) up to the board table, this is really the observation that all the professionals at that table would make:
Everyone would agree that NWBO’s management is terribly conflicted and that the fund manager (and Chief Executive for both entities) is leveraging one portfolio company that it controls to establish a second portfolio company that it wholly owns. Every other explanation would simply be rejected as self serving.
From a very real business perspective, that’s the obvious assessment. Tend to believe that’s why it’s been very difficult to attract investors outside of family funds and the occasional boutique investors like Bigger.
If it’s obvious to me living on a diet of noodles, sitting on a park bench, feeding pigeons, while stealing the WiFi from nearby coffee shops, it’s obvious to other professional investors.
Everyone would agree that NWBO’s management is terribly conflicted and that the fund manager (and Chief Executive for both entities) is leveraging one portfolio company that it controls to establish a second portfolio company that it wholly owns. Every other explanation would simply be rejected as self serving.
From a very real business perspective, that’s the obvious assessment. Tend to believe that’s why it’s been very difficult to attract investors outside of family funds and the occasional boutique investors like Bigger.
If it’s obvious to me living on a diet of noodles, sitting on a park bench, feeding pigeons, while stealing the WiFi from nearby coffee shops, it’s obvious to other professional investors.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
